The relationship between plasminogen activator inhibitor-1 levels and the course of disease in COVID-19 patients
Studies have shown that fibrinolysis activity is insufficient in COVID-19 patients. Plasminogen activator inhibitor-1 (PAI-1) is an important antifibrinolytic molecule that plays a key role in the fibrinolytic system. In our study; we aimed to evaluate serum PAI-1 and other biochemical parameters of...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2022-10-01
|
Series: | Türk Biyokimya Dergisi |
Subjects: | |
Online Access: | https://doi.org/10.1515/tjb-2022-0044 |
Summary: | Studies have shown that fibrinolysis activity is insufficient in COVID-19 patients. Plasminogen activator inhibitor-1 (PAI-1) is an important antifibrinolytic molecule that plays a key role in the fibrinolytic system. In our study; we aimed to evaluate serum PAI-1 and other biochemical parameters of COVID-19 patients in terms of disease course and mortality. |
---|---|
ISSN: | 1303-829X |